{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:24:37Z","timestamp":1791300277012,"version":"4.1.0"},"reference-count":60,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2010,4,29]],"date-time":"2010-04-29T00:00:00Z","timestamp":1272499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,6,7]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>Mesenchymal stem cell (MSC) therapy has shown promise clinically in graft-versus-host disease and in preclinical animal models of T helper type 1 (Th1)-driven autoimmune diseases, but whether MSCs can be used to treat autoimmune disease in general is unclear. Here, the therapeutic potential of MSCs was tested in the New Zealand black (NZB) \u00d7 New Zealand white (NZW) F1 (NZB\/W) lupus mouse model. The pathogenesis of systemic lupus erythematosus involves abnormal B and T cell activation leading to autoantibody formation. To test whether the immunomodulatory activity of MSCs would inhibit the development of autoimmune responses and provide a therapeutic benefit, NZB\/W mice were treated with Balb\/c-derived allogeneic MSCs starting before or after disease onset. Systemic MSC administration worsened disease and enhanced anti-double-stranded DNA (dsDNA) autoantibody production. The increase in autoantibody titres was accompanied by an increase in plasma cells in the bone marrow, an increase in glomerular immune complex deposition, more severe kidney pathology, and greater proteinuria. Co-culturing MSCs with plasma cells purified from NZB\/W mice led to an increase in immunoglobulin G antibody production, suggesting that MSCs might be augmenting plasma cell survival and function in MSC-treated animals. Our results suggest that MSC therapy may not be beneficial in Th2-type T cell- and B cell-driven diseases such as lupus and highlight the need to understand further the appropriate application of MSC therapy.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2010.04158.x","type":"journal-article","created":{"date-parts":[[2010,4,30]],"date-time":"2010-04-30T07:54:53Z","timestamp":1272614093000},"page":"176-186","source":"Crossref","is-referenced-by-count":76,"title":["Allogeneic mesenchymal stem cells do not protect NZB \u00d7 NZW F1 mice from developing lupus disease"],"prefix":"10.1093","volume":"161","author":[{"given":"M","family":"Youd","sequence":"first","affiliation":[{"name":"Stem Cell Biology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Blickarz","sequence":"additional","affiliation":[{"name":"Stem Cell Biology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Woodworth","sequence":"additional","affiliation":[{"name":"Immmunotherapy Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Touzjian","sequence":"additional","affiliation":[{"name":"Immmunotherapy Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Edling","sequence":"additional","affiliation":[{"name":"Immmunotherapy Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Tedstone","sequence":"additional","affiliation":[{"name":"Stem Cell Biology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Ruzek","sequence":"additional","affiliation":[{"name":"Immunology, Genzyme Corporation, Framingham, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Tubo","sequence":"additional","affiliation":[{"name":"Stem Cell Biology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Kaplan","sequence":"additional","affiliation":[{"name":"Immmunotherapy Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Lodie","sequence":"additional","affiliation":[{"name":"Stem Cell Biology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2010,4,29]]},"reference":[{"key":"2021122708484770400_b1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.blre.2005.11.002","article-title":"The role of mesenchymal stem cells in haemopoiesis","volume":"20","author":"Dazzi","year":"2006","journal-title":"Blood Rev"},{"key":"2021122708484770400_b2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"key":"2021122708484770400_b3","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.stem.2009.02.001","article-title":"Mesenchymal stem cell homing: the devil is in the details","volume":"4","author":"Karp","year":"2009","journal-title":"Cell Stem Cell"},{"key":"2021122708484770400_b4","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1182\/blood.V99.10.3838","article-title":"Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli","volume":"99","author":"Di Nicola","year":"2002","journal-title":"Blood"},{"key":"2021122708484770400_b5","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0301-472X(01)00769-X","article-title":"Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo","volume":"30","author":"Bartholomew","year":"2002","journal-title":"Exp Hematol"},{"key":"2021122708484770400_b6","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1182\/blood-2002-07-2104","article-title":"Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide","volume":"101","author":"Krampera","year":"2003","journal-title":"Blood"},{"key":"2021122708484770400_b7","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/01.TP.0000045055.63901.A9","article-title":"Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation","volume":"75","author":"Tse","year":"2003","journal-title":"Transplantation"},{"key":"2021122708484770400_b8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1365-3083.2003.01176.x","article-title":"Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex","volume":"57","author":"Le Blanc","year":"2003","journal-title":"Scand J Immunol"},{"key":"2021122708484770400_b9","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.4049\/jimmunol.171.7.3426","article-title":"Veto-like activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens","volume":"171","author":"Potian","year":"2003","journal-title":"J Immunol"},{"key":"2021122708484770400_b10","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1097\/01.TP.0000082540.43730.80","article-title":"Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells","volume":"76","author":"Rasmusson","year":"2003","journal-title":"Transplantation"},{"key":"2021122708484770400_b11","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1634\/stemcells.2004-0359","article-title":"Interactions between human mesenchymal stem cells and natural killer cells","volume":"24","author":"Sotiropoulou","year":"2006","journal-title":"Stem Cells"},{"key":"2021122708484770400_b12","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1182\/blood-2007-02-074997","article-title":"Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2","volume":"111","author":"Spaggiari","year":"2008","journal-title":"Blood"},{"key":"2021122708484770400_b13","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1182\/blood-2004-02-0586","article-title":"Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells","volume":"105","author":"Jiang","year":"2005","journal-title":"Blood"},{"key":"2021122708484770400_b14","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1182\/blood-2004-07-2921","article-title":"Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness","volume":"105","author":"Beyth","year":"2005","journal-title":"Blood"},{"key":"2021122708484770400_b15","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.4049\/jimmunol.177.4.2080","article-title":"Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells","volume":"177","author":"Nauta","year":"2006","journal-title":"J Immunol"},{"key":"2021122708484770400_b16","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1089\/154732804323099190","article-title":"Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells","volume":"13","author":"Zhang","year":"2004","journal-title":"Stem Cells Dev"},{"key":"2021122708484770400_b17","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1182\/blood-2005-07-2657","article-title":"Human mesenchymal stem cells modulate B-cell functions","volume":"107","author":"Corcione","year":"2006","journal-title":"Blood"},{"key":"2021122708484770400_b18","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1182\/blood-2004-09-3696","article-title":"Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells","volume":"105","author":"Glennie","year":"2005","journal-title":"Blood"},{"key":"2021122708484770400_b19","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1002\/eji.200425405","article-title":"Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway","volume":"35","author":"Augello","year":"2005","journal-title":"Eur J Immunol"},{"key":"2021122708484770400_b20","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.4049\/jimmunol.179.3.1855","article-title":"Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attentuates endotoxin-induced acute lung injury in mice","volume":"179","author":"Gupta","year":"2007","journal-title":"J Immunol"},{"key":"2021122708484770400_b21","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nm.1905","article-title":"Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production","volume":"15","author":"Nemeth","year":"2009","journal-title":"Nat Med"},{"key":"2021122708484770400_b22","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1182\/blood-2003-11-3909","article-title":"Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation","volume":"103","author":"Meisel","year":"2004","journal-title":"Blood"},{"key":"2021122708484770400_b23","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1182\/blood-2006-02-002246","article-title":"Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells","volume":"109","author":"Sato","year":"2007","journal-title":"Blood"},{"key":"2021122708484770400_b24","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.stem.2007.11.014","article-title":"Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide","volume":"2","author":"Ren","year":"2008","journal-title":"Cell Stem Cell"},{"key":"2021122708484770400_b25","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1182\/blood-2004-04-1559","article-title":"Human mesenchymal stem cells modulate allogeneic immune cell responses","volume":"105","author":"Aggarwal","year":"2005","journal-title":"Blood"},{"key":"2021122708484770400_b26","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/art.22511","article-title":"Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis","volume":"56","author":"Augello","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2021122708484770400_b27","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/ana.21076","article-title":"Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis","volume":"61","author":"Gerdoni","year":"2007","journal-title":"Ann Neurol"},{"key":"2021122708484770400_b28","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1182\/blood-2005-04-1496","article-title":"Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy","volume":"106","author":"Zappia","year":"2005","journal-title":"Blood"},{"key":"2021122708484770400_b29","doi-asserted-by":"crossref","first-page":"5994","DOI":"10.4049\/jimmunol.0803962","article-title":"Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner","volume":"182","author":"Rafei","year":"2009","journal-title":"J Immunol"},{"key":"2021122708484770400_b30","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1007\/s00125-009-1374-z","article-title":"Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells","volume":"52","author":"Madec","year":"2009","journal-title":"Diabetologia"},{"key":"2021122708484770400_b31","doi-asserted-by":"crossref","first-page":"993","DOI":"10.4049\/jimmunol.0900803","article-title":"Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes","volume":"183","author":"Fiorina","year":"2009","journal-title":"J Immunol"},{"key":"2021122708484770400_b32","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1046\/j.1365-2222.2001.01147.x","article-title":"Pathogenesis of systemic lupus erythematosus (SLE)","volume":"31","author":"Robson","year":"2001","journal-title":"Clin Exp Allergy"},{"key":"2021122708484770400_b33","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1182\/blood-2003-09-3070","article-title":"Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential","volume":"103","author":"Peister","year":"2004","journal-title":"Blood"},{"key":"2021122708484770400_b34","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1002\/1521-4141(200109)31:9<2726::AID-IMMU2726>3.0.CO;2-H","article-title":"Inflamed kidneys of NZB\/W mice are a major site for the homeostasis of plasma cells","volume":"31","author":"Cassese","year":"2001","journal-title":"Eur J Immunol"},{"key":"2021122708484770400_b35","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1002\/eji.200636416","article-title":"Immunoregulatory function of mesenchymal stem cells","volume":"36","author":"Uccelli","year":"2006","journal-title":"Eur J Immunol"},{"key":"2021122708484770400_b36","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1097\/01.tp.0000214462.63943.14","article-title":"Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease","volume":"81","author":"Ringden","year":"2006","journal-title":"Transplantation"},{"key":"2021122708484770400_b37","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.3324\/haematol.11446","article-title":"No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients","volume":"92","author":"Sundin","year":"2007","journal-title":"Haematologica"},{"key":"2021122708484770400_b38","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/0961203306075793","article-title":"Abnormality of bone marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus","volume":"16","author":"Sun","year":"2007","journal-title":"Lupus"},{"key":"2021122708484770400_b39","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s12026-007-0053-8","article-title":"Autoimmune disease: is it a disorder of the microenvironment?","volume":"41","author":"El-Badri","year":"2008","journal-title":"Immunol Res"},{"key":"2021122708484770400_b40","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.4049\/jimmunol.171.4.1684","article-title":"Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals","volume":"171","author":"Cassese","year":"2003","journal-title":"J Immunol"},{"key":"2021122708484770400_b41","first-page":"726","article-title":"Mesenchymal stem cells in health and disease","volume":"8","author":"Uccelli","year":"2008","journal-title":"Nat Rev"},{"key":"2021122708484770400_b42","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.it.2007.03.001","article-title":"Mesenchymal stem cells: a new strategy for immunosuppression?","volume":"28","author":"Uccelli","year":"2007","journal-title":"Trends Immunol"},{"key":"2021122708484770400_b43","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1128\/jvi.69.3.1895-1902.1995","article-title":"Bone marrow is a major site of long-term antibody production after acute viral infection","volume":"69","author":"Slifka","year":"1995","journal-title":"J Virol"},{"key":"2021122708484770400_b44","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/40540","article-title":"Lifetime of plasma cells in the bone marrow","volume":"388","author":"Manz","year":"1997","journal-title":"Nature"},{"key":"2021122708484770400_b45","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1074-7613(00)80541-5","article-title":"Humoral immunity due to long-lived plasma cells","volume":"8","author":"Slifka","year":"1998","journal-title":"Immunity"},{"key":"2021122708484770400_b46","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.4049\/jimmunol.169.8.4213","article-title":"The role of bone marrow-derived stromal cells in the maintenance of plasma cell longevity","volume":"169","author":"Minges Wols","year":"2002","journal-title":"J Immunol"},{"key":"2021122708484770400_b47","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0301-472X(00)00635-4","article-title":"Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion","volume":"29","author":"Devine","year":"2001","journal-title":"Exp Hematol"},{"key":"2021122708484770400_b48","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/sj.leu.2402763","article-title":"Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture","volume":"17","author":"Rombouts","year":"2003","journal-title":"Leukemia"},{"key":"2021122708484770400_b49","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.stem.2008.03.003","article-title":"Efficient homing of multipotent adult mesenchymal stem cells depends on FROUNT-mediated clustering of CCR2","volume":"2","author":"Belema-Bedada","year":"2008","journal-title":"Cell Stem Cell"},{"key":"2021122708484770400_b50","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1634\/stemcells.2007-0528","article-title":"Bone marrow-derived mesenchymal stem cells induce both polyclonal expansion and differentiation of B cells isolated from healthy donors and systemic lupus erythematosus patients","volume":"26","author":"Traggiai","year":"2008","journal-title":"Stem Cells"},{"key":"2021122708484770400_b51","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1365-3083.2007.01905.x","article-title":"Mesenchymal stem cells stimulate antibody secretion in human B cells","volume":"65","author":"Rasmusson","year":"2007","journal-title":"Scand J Immunol"},{"key":"2021122708484770400_b52","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1182\/blood.V85.2.487.487","article-title":"Differentiation of early plasma cells on bone marrow stromal cells requires interleukin-6 for escaping from apoptosis","volume":"85","author":"Kawano","year":"1995","journal-title":"Blood"},{"key":"2021122708484770400_b53","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1002\/eji.1830211105","article-title":"Terminal differentiation of human bone marrow cells capable of spontaneous and high-rate immunoglobulin secretion: role of bone marrow stromal cells and interleukin 6","volume":"21","author":"Roldan","year":"1991","journal-title":"Eur J Immunol"},{"key":"2021122708484770400_b54","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1089\/dna.2005.24.458","article-title":"Effects of allogeneic bone marrow-derived mesenchymal stem cells on T and B lymphocytes from BXSB mice","volume":"24","author":"Deng","year":"2005","journal-title":"DNA Cell Biol"},{"key":"2021122708484770400_b55","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1182\/blood-2008-07-166892","article-title":"Mesenchymal stromal cell-derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction","volume":"112","author":"Rafei","year":"2008","journal-title":"Blood"},{"key":"2021122708484770400_b56","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/978-1-4615-3396-2_14","article-title":"B-lymphocyte lineage-committed, IL-7 and stroma cell-reactive progenitors and precursors, and their differentiation to B cells","volume":"323","author":"Melchers","year":"1992","journal-title":"Adv Exp Med Biol"},{"key":"2021122708484770400_b57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/08830189809084486","article-title":"Interleukin-4 and interleukin-13: their similarities and discrepancies","volume":"17","author":"Chomarat","year":"1998","journal-title":"Int Rev Immunol"},{"key":"2021122708484770400_b58","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.4049\/jimmunol.169.3.1277","article-title":"Chemotactic responsiveness toward ligands for CXCR3 and CXCR4 is regulated on plasma blasts during the time course of a memory immune response","volume":"169","author":"Hauser","year":"2002","journal-title":"J Immunol"},{"key":"2021122708484770400_b59","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1182\/blood-2002-08-2383","article-title":"Macrophage inflammatory protein 1-alpha (MIP-1 alpha ) triggers migration and signaling cascades mediating survival and proliferation in multiple myeloma (MM) cells","volume":"101","author":"Lentzsch","year":"2003","journal-title":"Blood"},{"key":"2021122708484770400_b60","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/nm0109-18","article-title":"Mesenchymal stem cells combat sepsis","volume":"15","author":"Tyndall","year":"2009","journal-title":"Nat Med"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2010.04158.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/161\/1\/176\/41925172\/j.1365-2249.2010.04158.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/161\/1\/176\/41925172\/j.1365-2249.2010.04158.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T16:23:12Z","timestamp":1641054192000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/161\/1\/176\/6429054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,29]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2010,4,29]]},"published-print":{"date-parts":[[2010,6,7]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2010.04158.x","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2010,7]]},"published":{"date-parts":[[2010,4,29]]}}}